Crohn's & Colitis 360
Oxford University Press · United Kingdom · Est. 1995
Aims & Scope✦ Inferred from recent articles
Crohn's & Colitis 360 publishes research on inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). The journal focuses on treatment outcomes, including the efficacy and safety of various therapies such as JAK inhibitors (upadacitinib, tofacitinib, filgotinib), anti-TNF agents, and vedolizumab. Research also covers patient management, including family planning, pregnancy outcomes, mental health, quality of life, and the role of mobile health applications and pharmacist-led interventions. Additionally, the journal addresses complications of IBD, such as osteoporosis and cardiovascular events, and diagnostic tools like intestinal ultrasound and fecal testing.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Web of Science Categories
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref